OncoDaily Pulse

Aug 31, 2025, 15:50

Karima Oualla: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

The congress is free to attend.
Register via the link.

Co-Chair of VIRO

Images Name

Rana McKay
Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center

As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on
“Future Directions: Emerging Agents and Combinations.”

She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Karima Oualla

Dr. Karima Oualla is a Professor of Medical Oncology at Hassan II University Hospital in Morocco and a distinguished leader in oncology in the region.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Oualla will present on “The Current State of Renal Oncology in Morocco.” Her presentation will address:

The epidemiological and clinical landscape of renal cancer in Morocco.
Challenges and opportunities unique to renal oncology practice and research within the Moroccan healthcare system.
Innovative approaches and collaborations aimed at enhancing patient care and outcomes.
Strategies to foster growth in regional research and multidisciplinary oncology.

Leveraging her extensive experience and academic leadership, Dr. Oualla emphasizes the importance of tailored, culturally aware oncology care and the advancement of knowledge to improve renal cancer outcomes in Morocco and the broader North African region.

Global Voices in Renal Oncology (VIRO) 2025